Phenylalanine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

L-Phenylalanine is the fastest growing sector, North America is the largest market

The Global Phenylalanine Market is projected to expand from USD 585.54 Million in 2025 to USD 746.04 Million by 2031, registering a CAGR of 4.12%. Phenylalanine serves as an essential amino acid and a precursor to tyrosine, playing a vital role in the biosynthesis of neurotransmitters such as dopamine and norepinephrine. The market is primarily propelled by strong demand for the artificial sweetener aspartame, a key ingredient in low-calorie food and beverage items. Furthermore, the pharmaceutical industry utilizes the compound to treat conditions like depression and vitiligo, while the animal nutrition sector employs it to enhance protein synthesis in livestock feed, solidifying these industries as the core drivers of sustained market demand.

However, market growth encounters significant hurdles due to supply chain concentration and geopolitical dependency, which expose stakeholders to risks regarding availability and pricing volatility. This vulnerability is intensified by the heavy reliance of major economies on specific manufacturing hubs for raw materials. For instance, the Institute for Feed Education and Research reported that in 2024, the United States depended on China for roughly 62% of its amino acid production needs. Such centralized manufacturing capacity creates distinct risks for the phenylalanine market, as trade disruptions or regulatory changes in the dominant production region could trigger immediate supply shortages.

Market Drivers

The Global Phenylalanine Market is significantly driven by the surging global demand for low-calorie aspartame sweeteners, as this amino acid acts as a primary precursor for aspartame production. Driven by increasing health awareness and sugar taxation policies, beverage manufacturers are aggressively expanding their zero-sugar portfolios, thereby boosting the industrial requirement for high-purity phenylalanine. This trend is evident in the strong uptake of sugar-free offerings by major players; for example, The Coca-Cola Company reported in October 2025 that its Coca-Cola Zero Sugar line achieved a 14% volume increase during the third quarter, highlighting the critical role of aspartame-based formulations in stimulating upstream ingredient consumption.

Simultaneously, the market is supported by the growing adoption of high-quality animal feed additives, where phenylalanine is utilized to optimize protein synthesis and improve feed conversion ratios. As the agricultural sector adopts precision nutrition to minimize environmental impact, including essential amino acids in feed has become standard practice for ensuring food security. According to Alltech, global feed production rose by 1.2% in 2024 to reach 1.396 billion metric tons by May 2025, establishing a stable foundation for additive demand. Reflecting the sector's massive scale, The Korea Economic Daily noted in December 2024 that CJ CheilJedang's bio division was expected to exceed 4 trillion won in annual revenue, underscoring the substantial economic value generated by amino acid production for animal nutrition.

Market Challenges

The concentration of supply chains and geopolitical dependency presents a formidable obstacle to the growth of the Global Phenylalanine Market. This vulnerability impedes expansion by creating a single point of failure where localized disruptions - ranging from regulatory shifts to logistical bottlenecks - can cascade into immediate global shortages. Since phenylalanine production is heavily consolidated within limited geographic regions, the market lacks the manufacturing redundancy required to absorb shocks. Consequently, downstream sectors such as the food and beverage industry, which rely on the compound for aspartame, face unpredictable procurement cycles and extreme pricing volatility, forcing companies to operate defensively and limiting their ability to scale or innovate due to raw material insecurity.

The extent of this manufacturing monopolization places global stakeholders in a precarious position regarding inventory security. According to the American Feed Industry Association, in 2025, China controlled approximately 77% of the global supply for lysine and 91% for threonine, indicating a systemic centralization across the amino acid sector that mirrors the landscape for phenylalanine. This overwhelming dominance by a single manufacturing hub means that global pricing structures are often dictated by one nation's policy decisions rather than organic supply and demand mechanics. Such profound dependency discourages long-term capital investment from international buyers who view the lack of alternative supply sources as an unmanageable operational risk, thereby stifling overall market growth.

Market Trends

The pharmaceutical sector is increasingly utilizing phenylalanine as a critical building block for synthesizing novel peptide drugs, moving beyond its traditional role as a simple excipient. This trend is largely fueled by the explosive demand for peptide-based therapeutics, particularly GLP-1 receptor agonists used in diabetes care and weight management, which rely on precise amino acid sequences for efficacy. As these complex biologics capture more market share, the need for high-purity phenylalanine for peptide synthesis has surged to support upstream drug development. Neuland Labs noted in a September 2024 article on peptide trends that clinical trials for obesity drugs increased by 68% in 2023, signaling a robust trajectory for amino acid consumption in this high-value segment.

Concurrently, manufacturers are shifting from chemical synthesis to advanced microbial fermentation processes, which offer higher yield efficiency and improved sustainability profiles. This transition allows producers to mitigate the environmental impact of traditional petrochemical methods while scaling operations to meet global needs. Industry players are investing heavily in new infrastructure to support this bio-based production model, securing raw material access and reducing costs through vertical integration. For instance, Interfax reported in November 2024 that Fufeng Group plans to invest up to USD 350 million to establish a vertically integrated industrial park in Kazakhstan for corn processing and amino acid bio-fermentation, highlighting the significant capital flow into modernizing manufacturing capabilities.

Key Market Players

• Ajinomoto Co., Inc.
• DAESANG
• Livzon
• KYOWA HAKKO BIO CO., LTD
• Amazing Nutrition
• AMINO GmbH
• Wuxi Jinghai Amino Acid Co., Ltd
• Shijiazhuang Jirong Pharmaceutical Co., Ltd
• Shijiazhuang Haitian Amino Acid Co., Ltd

Report Scope

In this report, the Global Phenylalanine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Phenylalanine Market, by Type:

• L-Phenylalanine
• D-Phenylalanine
• DL-Phenylalanine

Phenylalanine Market, by Application:

• Depression
• Attention Deficit Disorder
• Parkinson disease
• Chronic Pain
• Vitiligo
• Others

Phenylalanine Market, by End-Users:

• Food and Beverage
• Dietary Supplements
• Pharmaceuticals
• Others

Phenylalanine Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Phenylalanine Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.